Our lab is proud to have played a key role in advancing gene therapy research by conducting the human retina testing for a novel base editing approach targeting Stargardt disease. Using our ex vivo postmortem retina explant system, we evaluated the effectiveness of this precision gene editing technology on human retina samples, providing critical insights into its potential for clinical application.
This study, featured in Nature Medicine, represents a major advancement in the field.